TI
ABBV icon

Tidal Investments’s AbbVie ABBV Stock Holding History

Tidal Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$147M Buy
585,879
+87,932
+18% +$18.9M 0.26% 75
2026
Q1 		$107M Buy
497,947
+297,845
+149% +$66.1M 0.23% 95
2025
Q4 		$45.7M Buy
200,102
+36,485
+22% +$8.31M 0.11% 170
2025
Q3 		$37.9M Buy
163,617
+24,228
+17% +$4.93M 0.08% 200
2025
Q2 		$25.9M Buy
139,389
+9,514
+7% +$1.77M 0.16% 175
2025
Q1 		$27.2M Sell
129,875
-5,867
-4% -$1.14M 0.22% 98
2024
Q4 		$24.1M Buy
135,742
+22,367
+20% +$4.11M 0.19% 135
2024
Q3 		$22.4M Buy
113,375
+780
+0.7% +$146K 0.24% 93
2024
Q2 		$19.3M Buy
112,595
+12,566
+13% +$2.08M 0.26% 75
2024
Q1 		$18.2M Buy
100,029
+32,845
+49% +$5.66M 0.3% 68
2023
Q4 		$10.4M Sell
67,184
-9,964
-13% -$1.45M 0.24% 79
2023
Q3 		$11.5M Buy
77,148
+3,698
+5% +$543K 0.35% 47
2023
Q2 		$9.9M Buy
73,450
+7,355
+11% +$1.08M 0.29% 58
2023
Q1 		$10.5M Sell
66,095
-10,012
-13% -$1.53M 0.35% 48
2022
Q4 		$12.3M Buy
76,107
+2,246
+3% +$344K 0.47% 35
2022
Q3 		$9.91M Buy
73,861
+4,691
+7% +$673K 0.41% 43
2022
Q2 		$10.6M Buy
69,170
+356
+0.5% +$54.4K 0.39% 44
2022
Q1 		$11.2M Buy
68,814
+12,897
+23% +$1.87M 0.33% 52
2021
Q4 		$7.57M Buy
55,917
+7,671
+16% +$906K 0.23% 69
2021
Q3 		$5.21M Buy
48,246
+19,438
+67% +$2.22M 0.2% 71
2021
Q2 		$3.25M Buy
28,808
+11,733
+69% +$1.32M 0.13% 111
2021
Q1 		$1.85M Buy
17,075
+5,558
+48% +$594K 0.09% 122
2020
Q4 		$1.23M Buy
11,517
+4,131
+56% +$397K 0.09% 126
2020
Q3 		$647K Buy
7,386
+1,006
+16% +$94.7K 0.09% 129
2020
Q2 		$626K Buy
6,380
+2,158
+51% +$190K 0.09% 138
2020
Q1 		$322K Sell
4,222
-99
-2% -$8.43K 0.1% 155
2019
Q4 		$383K Buy
4,321
+1,222
+39% +$101K 0.16% 128
2019
Q3 		$235K Buy
+3,099
New +$212K 0.11% 148

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tidal Investments's ABBV Position: Q2 2026 in Review

Tidal Investments increased its AbbVie (ABBV) stake by 18% in Q2 2026, buying an estimated $18.9M and bringing the position to 585,879 shares worth $147M. The position accounts for 0.26% of the portfolio, ranked #75.

Tidal Investments first reported a position in ABBV in Q3 2019 and has held it in 28 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Tidal Investments held 585,879 shares of AbbVie worth $147M as of Q2 2026.
  • Tidal Investments bought 87,932 AbbVie shares in Q2 2026, an estimated $18.9M.
  • AbbVie made up 0.26% of Tidal Investments's portfolio in Q2 2026, its #75 holding.
  • Tidal Investments first reported a position in AbbVie in Q3 2019 and has held it in 28 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.